InsidersTradesSigma
Track the 리브스메드 share price and the full insider trade history of the company, a listed issuer based in South Korea. Shares are quoted on the KR market, under the authority of DART (FSS). Operating in the Health Care sector, 리브스메드 has recorded 21 insider filings. Market capitalisation: €1,009.5bn. The latest transaction was reported on 22 April 2026 (Purchase). Among the most active insiders: 스톤브릿지벤처스. All data is openly available.
21
Insider Decl.
n/a
Thresholds
n/a
14 ops.
Buy Volume
n/a
6 ops.
Sell Volume
16Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
Last declaration on 22 April 2026
Declarations21 total
1,465,662 sharesKRXDART:20260407003261
21 of 21 declarations
关于 리브스메드
리브스메드在医疗保健和制药领域运营，在XKRX市场上市。该公司专注于开发创新的医疗保健解决方案。